The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists
- 10 February 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 56 (11-12) , 837-844
- https://doi.org/10.1016/0024-3205(95)00018-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Actions of methoctramine, a muscarinic M2 receptor antagonist, on muscarinic and nicotinic cholinoceptors in guinea‐pig airways in vivo and in vitroBritish Journal of Pharmacology, 1992
- The Potential for Muscarinic Receptor Subtype-Specific Pharmacotherapy for Alzheimer's DiseaseMayo Clinic Proceedings, 1991
- Polymethylene tetraamines: A novel class of cardioselective M2‐antagonistsMedicinal Research Reviews, 1990
- Muscarinic Receptor SubtypesAnnual Review of Pharmacology and Toxicology, 1990
- The molecular basis of muscarinic receptor diversityTrends in Neurosciences, 1989
- Structure-activity relationships among methoctramine-related polymethylenetetramines. Chain length and substituent effects on M-2 muscarinic receptor blocking activityJournal of Medicinal Chemistry, 1989
- The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitroBritish Journal of Pharmacology, 1988
- Polymethylene tetramines: a new generation of selective muscarinic antagonistsTrends in Pharmacological Sciences, 1988
- Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptorsJournal of Medicinal Chemistry, 1987